Results of a Phase I Trial of Sorafenib (BAY 43-9006) in Combination with Oxaliplatin in Patients with Refractory Solid Tumors, Including Colorectal Cancer
Petra Kupsch, Bernhard F. Henning, Katrin Passarge, Heike Richly, Katrin Wiesemann, Ralf A. Hilger, Max E. Scheulen, Olaf Christensen, Erich Brendel, Brian Schwartz, Elke Hofstra, Rudolf Voigtmann, SiVolume:
5
Year:
2005
Language:
english
DOI:
10.3816/ccc.2005.n.030
File:
PDF, 503 KB
english, 2005